Home - GORTEC - GROUPE ONCOLOGIE RADIOTHERAPIE TETE ET COU

OUR MISSION

Coordinate clinical and/or laboratory studies.

PUBLICATIONS

GORTEC publications.

Trials

Find all trials.

Next GORTEC and Intergroupe ORL biannual meeting in Lille on June 20 and 21

The next GORTEC and Intergroupe ORL meeting will be held in Lille on Thursday 20 and Friday 21 of June 2019.

It will be preceded by the 2nd Immuno-Oncology Conference for ENT cancers.

Online enrollments are now closed. For any questions please contact Stephanie Roy stephanie.roy[@]gortec.fr.

To download the provisional program of the GORTEC and Intergroupe ORL meeting, click here. To download the program of the 2nd Immuno-Oncology Conference for ENT cancers, click here.

GORTEC and Intergroupe ORL journal

The latest edition of the Gortec journal (n°18- April 2019) is now available. Click the image to download

Chairman’s message

Jean Bourhis Oncology and Radiotherapy CHUV

Dear colleagues and friends,

We are all working together - at GORTEC, Unicancer, GETTEC, GERCOR and now REFCOR - to develop a truly remarkable shared momentum to support clinical research and optimize the treatment of head and neck cancers. Our clinical trials stand out within the global panorama in terms of both number and quality. A significant proportion of our research concerns trials without links to the pharmaceutical industry (Cisfrad, Saltorl, Santal, etc.) and we are also at the forefront when it comes to asking major questions - via the TPextreme trial, for example - and incorporating the latest developments in the field of immunotherapy (REACH, PembroRad, TopNivo, Nivo post-op, Rewrite, Frail-immune etc.).

We owe our success to the invaluable contributions made by each and every one of you and by each investigator site, and also to the support and motivation of our operational teams, to whom I wish to extend my warmest thanks.